Long-Term Visual Prognosis of Patients Following Lens-Sparing Vitrectomy for Stage 4A Retinopathy of Prematurity
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24032416 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Chiharu Iwahashi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Faculty of Medicine, Kindai University, Osakasayama 589-8511, Japan. Hauptthemen laut MEDLINE: Retinopathy of Prematurity, Myopia, Infant, Newborn, Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: a grant-in-aid from the Ministry of Education, Culture, Sport, Science and Technology, Japan, Ministry of Education, Culture, Sport, Science and Technology, Japan.
Abstract (Originalsprache)
This study evaluated the long-term visual outcomes of patients in whom at least one eye underwent successful lens-sparing vitrectomy (LSV) for stage 4A retinopathy of prematurity (ROP). A retrospective chart review was conducted using the data of 61 eyes of 42 patients with a minimum 4-year follow-up after successful LSV, with or without anti-vascular endothelial growth factor (VEGF) therapy, and whose best-corrected visual acuity (BCVA) was measurable using Landolt rings at the final visit. The mean age at the final follow-up was 10.1 ± 3.3 years. Before LSV, all eyes underwent laser ablation therapy. Twenty eyes (32.8%) with high vascular activity received anti-VEGF therapy before LSV. The mean decimal BCVA at the final follow-up was 0.23 ± 0.26 (range: hand motion to 1.2). Twenty-three eyes (54.1%) had a decimal BCVA of ≥0.4. Among 49 phakic eyes at the final examination, the mean refractive error was −10.1 ± 5.0 D, with 37 eyes (75.5%) having high myopia (>−6.0 D). No significant differences were observed in terms of decimal BCVA and refractive errors between eyes with and without anti-VEGF therapy. Approximately half of the patients had a decimal BCVA of ≥0.4, despite myopic refraction after successful LSV for stage 4A ROP. LSV for stage 4A ROP seemed to be associated with good visual function, despite myopic refraction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, Faculty of Medicine, Kindai University, Osakasayama 589-8511, Japan.
ORCID-Profile: Chiharu Iwahashi, Shunji Kusaka
Förderung
- a grant-in-aid from the Ministry of Education, Culture, Sport, Science and Technology, Japan
- Ministry of Education, Culture, Sport, Science and Technology, Japan
Zitieren
APA
Iwahashi, C., Kurihara, T., Kuniyoshi, K., & Kusaka, S. (2023). Long-Term Visual Prognosis of Patients Following Lens-Sparing Vitrectomy for Stage 4A Retinopathy of Prematurity. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24032416
Vancouver
Iwahashi C, Kurihara T, Kuniyoshi K, Kusaka S. Long-Term Visual Prognosis of Patients Following Lens-Sparing Vitrectomy for Stage 4A Retinopathy of Prematurity. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24032416
BibTeX
@article{Iwahashi2023,
author = {Iwahashi, Chiharu and Kurihara, Tomoki and Kuniyoshi, Kazuki and Kusaka, Shunji},
title = {Long-Term Visual Prognosis of Patients Following Lens-Sparing Vitrectomy for Stage 4A Retinopathy of Prematurity},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24032416}
}
EUVIMED